Levi9 has successfully raised financing
Levi9 has successfully raised fundraising. The facilities were provided by Rabobank.
Levi9 is a software service and outsourcing company specialized in developing and maintaining mission-critical software applications. Developers assist their customers at every stage of their IT/business transformation, from technology selection to application developments, system integration and maintenance. The company has experienced strong growth in the last years on the back of a growing number of software-driven companies and as a result a growing demand for software developers.
Oaklins' debt advisory team in the Netherlands acted as exclusive debt advisor to the company. The team assisted Levi9 in establishing a financing package that is aligned with their current business profile and supports management’s ambitions for the long term.


Talk to the deal team
Related deals
BodhiCedric has acquired Network Media from Jellysmack
The media holding company BodhiCedric has acquired Network Media, an innovator in the creator economy, from Jellysmack, the global creator company.
Learn moreCustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn more